COSMECEUTICALS: BIOACTIVE INGREDIENTS, MECHANISMS OF ACTION, FORMULATION TECHNOLOGIES, SAFETY, REGULATORY CHALLENGES AND FUTURE PERSPECTIVES-A COMPREHENSIVE REVIEW

  • Kushal Saini Sri Balaji College of Pharmacy Jaipur, Rajasthan
  • Anil Kumar Sri Balaji College of Pharmacy Jaipur, Rajasthan
  • Neha Bandil Sri Balaji College of Pharmacy Jaipur, Rajasthan
  • Pawan Kumar Basniwal Sri Balaji College of Pharmacy Jaipur, Rajasthan

Abstract

Cosmeceuticals represent a rapidly developing interdisciplinary field positioned at the interface of cosmetic science, pharmaceutical technology, dermatology, biotechnology, and personal care. The term generally describes cosmetic preparations containing biologically active ingredients intended to provide benefits beyond conventional cleansing, beautification, or temporary modification of appearance. Although the term “cosmeceutical” is extensively used in scientific literature and the cosmetic industry, it does not constitute a universally recognized independent regulatory category. Product classification is therefore frequently determined by composition, intended use, and the claims made by the manufacturer. The increasing demand for healthy-looking skin, preventive skin care, anti-aging products, photoprotection, skin brightening, and naturally derived formulations has stimulated substantial development in cosmeceutical research. Contemporary products incorporate a broad range of bioactive ingredients, including vitamins, antioxidants, hydroxy acids, peptides, retinoid-related compounds, ceramides, hyaluronic acid, botanical extracts, and ultraviolet filters. Their proposed activities include enhancement of skin hydration, maintenance of the skin barrier, reduction of oxidative stress, modulation of epidermal turnover, improvement of skin texture and pigmentation, and protection against environmental stressors. However, the efficacy of a cosmeceutical product cannot be determined solely from the presence of an active ingredient. Concentration, chemical form, physicochemical properties, stability, formulation, release characteristics, skin penetration, packaging, duration of use, and clinical evidence can substantially influence performance. Advanced delivery systems such as liposomes, nanoemulsions, microemulsions, solid lipid nanoparticles, nanostructured lipid carriers, and other encapsulation systems have consequently become important approaches for improving the stability and delivery of sensitive or poorly soluble ingredients. This review provides a comprehensive discussion of the evolution and classification of cosmeceuticals, skin structure and barrier function, major active ingredients and their mechanisms, moisturizing, anti-aging, antioxidant, photoprotective, exfoliating, skin-brightening, anti-acne, herbal, and hair-care applications, advanced delivery systems, formulation considerations, safety and quality-control requirements, scientific evidence, and regulatory challenges. Particular emphasis is placed on the need for evidence-based product development, standardization of natural ingredients, robust clinical evaluation, long-term safety assessment, and scientifically justified cosmetic claims. Future development of cosmeceuticals is expected to increasingly emphasize targeted delivery, formulation stability, personalized products, biotechnology-derived ingredients, and evidence-based efficacy while maintaining consumer safety and regulatory compliance potential.


 


 

Keywords: Cosmeceuticals, bioactive ingredients, skin care, anti-aging, antioxidants, peptides, retinoids, hyaluronic acid, herbal cosmetics, nanocarriers, topical delivery, formulation, regulatory science

References

1. Kligman AM. Cosmeceuticals: The concept and its evolution. Dermatologic Clinics. 2000.
2. Draelos ZD. Cosmeceuticals: undefined, unclassified, and unregulated. Clinics in Dermatology. 2009;27(5):431–434.
3. Draelos ZD. Cosmetic Dermatology: Products and Procedures. Wiley-Blackwell; 2010.
4. Brandt FS, Cazzaniga A, Hann M. Cosmeceuticals: current trends and market analysis. Seminars in Cutaneous Medicine and Surgery. 2011;30(3):141–143.
5. Draelos ZD. Cosmeceuticals: What’s real, what’s not. Dermatologic Clinics. 2019;37(1):107–115.
6. Tetali B, Fahs FM, Mehregan D. Popular over-the-counter cosmeceutical ingredients and their clinical efficacy. International Journal of Dermatology. 2020;59(4):393–405.
7. Crous C, Pretorius J, Petzer A. Overview of popular cosmeceuticals in dermatology. Skin Health and Disease. 2024;4(2).
8. Nguyen JK, Masub N, Jagdeo J. Bioactive ingredients in Korean cosmeceuticals: trends and research evidence. Journal of Cosmetic Dermatology. 2020.
9. Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clinical Interventions in Aging. 2006.
10. Sorg O, Antille C, Kaya G, Saurat JH. Retinoids in cosmeceuticals. Dermatologic Therapy. 2006;19(5):289–296.
11. Stratigos AJ, Katsambas AD. The role of topical retinoids in the treatment of photoaging. Drugs. 2005;65:1061–1072.
12. Kafi R, Kwak HSR, Schumacher WE, et al. Improvement of naturally aged skin with vitamin A: a clinical study. Archives of Dermatology. 2007;143(5):606–612.
13. Pullar JM, Carr AC, Vissers MCM. The roles of vitamin C in skin health. Nutrients. 2017;9(8):866.
14. Burke KE. Interaction of vitamins C and E as better cosmeceuticals. Dermatologic Therapy. 2007;20(5):314–321.
15. Farris PK. Topical vitamin C: a useful agent for treating photoaging and other dermatologic conditions. Dermatologic Surgery. 2005;31(7):814–818.
16. Zussman J, Ahdout J, Kim J. Vitamins and photoaging: do vitamin A, B, C, and E reverse signs of aging? Journal of Drugs in Dermatology. 2010;9(1):15–23.
17. Bissett DL. Topical niacinamide and skin aging. Dermatologic Surgery. 2005;31(7):860–865.
18. Gehring W, Gehlsen M. Nicotinamide—mechanisms of action and its topical use in dermatology. Skin Pharmacology and Physiology. 2003;16:183–190.
19. Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: a key molecule in skin aging. Dermato-Endocrinology. 2012;4(3):253–258.
20. Pavicic T, Gauglitz GG, Lersch P, et al. Efficacy of topical hyaluronic acid in skin rejuvenation. Journal of Drugs in Dermatology. 2011;10(9):990–1000.
21. Robinson LR, Fitzgerald NC, Doughty DG, et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. International Journal of Cosmetic Science. 2005;27(3):155–160.
22. Schagen SK. Topical peptide treatments with effective anti-aging results. Cosmetics. 2017;4(2):16.
23. Aguilar-Toalá JE, Hernández-Mendoza A, González-Córdova AF, Vallejo-Cordoba B, Liceaga A. Potential role of natural bioactive peptides for development of cosmeceutical skin products. Peptides. 2019;122:170170.
24. Draelos ZD. The cosmeceutical realm. Clinics in Dermatology. 2008;26(6):627–632.
25. Kligman AM. The treatment of photoaged skin by topical tretinoin. British Journal of Dermatology. 1988.
26. Green LJ, McCormick A, Weinstein GD. Photoaging and topical retinoids. Dermatologic Therapy. 1999.
27. Ditre CM, Griffin TD, Murphy GF, Sueki H, Telegan B, Johnson WC, et al. Effects of alpha hydroxy acids on photoaged skin: a pilot clinical, histologic, and ultrastructural study. Journal of the American Academy of Dermatology. 1996;34(2):187–195.
28. Tang SC, Yang JH. Dual effects of alpha-hydroxy acids on the skin. Molecules. 2018;23(4):863.
29. Draelos ZD. The science behind skin care: moisturizers. Journal of Cosmetic Dermatology. 2018.
30. Jagdeo J, Hoss E, Jacob SE, et al. Cosmeceuticals for antiaging: a systematic review of safety and efficacy. International Journal of Dermatology. 2024.
31. U.S. Food and Drug Administration. Cosmeceutical. Center for Food Safety and Applied Nutrition.
32. U.S. Food and Drug Administration. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?).
33. U.S. Food and Drug Administration. Cosmetics & U.S. Law.
34. World Health Organization. WHO Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems. Geneva: WHO.
35. European Commission. Regulation (EC) No 1223/2009 on Cosmetic Products. European Union.
36. Cosmeceuticals for Anti-Aging: Mechanisms, Clinical Evidence, and Regulatory Insights—A Comprehensive Review. Cosmetics. 2025;12(5):209.
Statistics
0 Views | 0 Downloads
How to Cite
Kushal Saini, Anil Kumar, Neha Bandil, and Pawan Kumar Basniwal. “COSMECEUTICALS: BIOACTIVE INGREDIENTS, MECHANISMS OF ACTION, FORMULATION TECHNOLOGIES, SAFETY, REGULATORY CHALLENGES AND FUTURE PERSPECTIVES-A COMPREHENSIVE REVIEW”. Current Research in Pharmaceutical Sciences, Vol. 16, no. 3, Sept. 2026, pp. 39-47, doi:10.24092/CRPS.2026.160302.
Section
Review Articles